18.05.2022 | Research Letter
Using echocardiography in newborn screening for congenital heart disease may reduce missed diagnoses
verfasst von:
Yun-Xiang Qiu, Wei Jiang, Jia-Yu Zhang, Die Li, Kai Yu, Cang-Cang Fu, Xiao-Min Tang, Wei-Ze Xu
Erschienen in:
World Journal of Pediatrics
|
Ausgabe 9/2022
Einloggen, um Zugang zu erhalten
Excerpt
Congenital heart disease (CHD) is the most common type of birth defect in China. According to a national study, the overall prevalences of CHD and critical CHD were 8.98 per 1000 live births and 1.46 per 1000 live births, respectively, in China [
1]. CHD, particularly critical CHD, not only seriously affects the quality of life of patients and their family, but creates huge economic and mental burdens on the family and on society as a whole [
2]. Early diagnosis of CHD is imperative for early intervention and treatment. For early diagnosis of CHD, CHD screening in all newborns was first initiated in Shanghai, China on June 1, 2016 [
3]. Since July 30, 2018, the China National Health Commission initiated newborn screening program for CHD; “double index methods” (cardiac auscultation plus pulse oximetry) were used to screen CHD for newborns 6 hours and 72 hours after birth. …